3/8/22 21:00 | 3/7/22 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | S.d | -54 | 12.01 | 0 | -5 | -1 | 312 | D | | | | | | | | | | | | | | |
11/19/21 16:59 | 11/17/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | M.dm | 26 | 6.55 | 0 | 4 | 6 | 69 | D | | | | | | | | | | | | | | |
11/19/21 16:59 | 11/17/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | S.dm | -128 | 32.00 | 0 | -4 | -5 | 69 | D | | | | | | | | | | | | | | |
10/21/21 21:00 | 10/19/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | M.dm | 73 | 6.55 | 0 | 11 | 19 | 69 | D | | | | | | | | | | | | | | |
10/21/21 21:00 | 10/19/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | S.dm | -378 | 33.71 | 0 | -11 | -14 | 69 | D | | | | | | | | | | | | | | |
10/8/21 19:00 | 10/6/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | M.dm | 74 | 6.32 | 0 | 12 | 20 | 69 | D | | | | | | | | | | | | | | |
10/8/21 19:00 | 10/6/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | S.dm | -385 | 32.95 | 0 | -12 | -14 | 69 | D | | | | | | | | | | | | | | |
9/15/21 19:51 | 9/13/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | M.dm | 74 | 6.32 | 0 | 12 | 20 | 69 | D | | | | | | | | | | | | | | |
9/15/21 19:51 | 9/13/21 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | S.dm | -432 | 36.98 | 0 | -12 | -14 | 69 | D | | | | | | | | | | | | | | |